Evidence map›Paper›PMID 33809496›Full record

ArticleMolecules (Basel, Switzerland)2021

Anti-Cancer Effects of Carnosine-A Dipeptide Molecule.

Monica D Prakash, Sarah Fraser, Jennifer C Boer, Magdalena Plebanski, Barbora de Courten, Vasso Apostolopoulos

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 42 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. The Possible Roles ofCurrent medicinal chemistry · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Monica D PrakashInstitute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.ORCID 0000-0002-2814-7560
Sarah FraserInstitute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.
Jennifer C BoerTranslational Immunology and Nanotechnology Research Program, School of Health and Biomedical Science, RMIT University, Melbourne, VIC 3083, Australia.ORCID 0000-0002-7053-0627
Magdalena PlebanskiTranslational Immunology and Nanotechnology Research Program, School of Health and Biomedical Science, RMIT University, Melbourne, VIC 3083, Australia.ORCID 0000-0001-6889-3667
Barbora de CourtenDepartment of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC 3168, Australia.ORCID 0000-0001-8760-2511
Vasso ApostolopoulosInstitute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.ORCID 0000-0001-6788-2771
Victoria University · AURMIT University · AUMonash University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCarnosine is a dipeptide molecule (β-alanyl-l-histidine) with anti-inflammatory, antioxidant, anti-glycation, and chelating properties. It is used in exercise physiology as a food supplement to increase performance; however, in vitro evidence suggests that carnosine may exhibit anti-cancer properties.

methodsIn this study, we investigated the effect of carnosine on breast, ovarian, colon, and leukemic cancer cell proliferation. We further examined U937 promonocytic, human myeloid leukemia cell phenotype, gene expression, and cytokine secretion to determine if these are linked to carnosine's anti-proliferative properties.

resultsCarnosine (1) inhibits breast, ovarian, colon, and leukemic cancer cell proliferation; (2) upregulates expression of pro-inflammatory molecules; (3) modulates cytokine secretion; and (4) alters U937 differentiation and phenotype.

conclusionThese effects may have implications for a role for carnosine in anti-cancer therapy.

Indexed as

Antineoplastic AgentsCarnosineCell DifferentiationCell Line, TumorCell ProliferationCytokinesDipeptidesGene ExpressionHT29 CellsHumansNeoplasmsU937 CellsAntineoplastic AgentsCarnosineCytokinesDipeptidesanti-cancercarnosinecytokineimmunomodulationβ-alanyl-l-histidine

Identifiers

PMID33809496
PMCPMC8002160
OpenAlexW3136523828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.